Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters








Database
Language
Publication year range
1.
Nature ; 430(6996): 1 p following 165; discussion 2 p following 165, 2004 Jul 08.
Article in English | MEDLINE | ID: mdl-15243972

ABSTRACT

Batterham et al. report that the gut peptide hormone PYY3-36 decreases food intake and body-weight gain in rodents, a discovery that has been heralded as potentially offering a new therapy for obesity. However, we have been unable to replicate their results. Although the reasons for this discrepancy remain undetermined, an effective anti-obesity drug ultimately must produce its effects across a range of situations. The fact that the findings of Batterham et al. cannot easily be replicated calls into question the potential value of an anti-obesity approach that is based on administration of PYY3-36.


Subject(s)
Appetite Depressants/pharmacology , Appetite Regulation/drug effects , Feeding Behavior/drug effects , Peptide YY/pharmacology , Animals , Animals, Inbred Strains , Appetite/drug effects , Appetite/physiology , Appetite Depressants/therapeutic use , Behavior, Animal/drug effects , Body Weight/drug effects , Environment , Humans , Meta-Analysis as Topic , Mice , Obesity/drug therapy , Peptide Fragments , Peptide YY/administration & dosage , Peptide YY/blood , Peptide YY/therapeutic use , Rats , Reproducibility of Results , Stress, Physiological/complications , Stress, Physiological/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL